Skip to content

Study on influencing factors and curative effect of interventional treatment for non acute symptomatic anterior circulation artery occlusion

Study on influencing factors and curative effect of interventional treatment for non acute symptomatic anterior circulation artery occlusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050113
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral vascular disease

Interventions

Experimental group:drug + interventional therapy

Sponsors

People's Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Symptomatic: cerebral infarction or TIA related to occluded blood vessels, cognitive impairment or monocular vision loss, etc.; 3. Hemodynamics: There is no forward blood flow signal in the internal carotid artery or middle cerebral artery confirmed by vascular imaging examination (TIMI grade is 0); 4. CT or MRI perfusion imaging indicates insufficient perfusion in the responsible vessel area; 5. The occlusion time to the interventional treatment time exceeds 24 hours; 6. The patient or legal representative signs the consent form.

Exclusion criteria

Exclusion criteria: 1. Both anterior circulation arteries were occluded; 2. Moyamoya disease; 3. DSA confirmed the occlusion from the C1 segment of the internal carotid artery to the M1 segment of the middle cerebral artery; 4. Intracranial hemorrhage in the past 3 months; 5. Obvious disability before the disease (mRS>3 points); 6. Known severe allergy to iodine contrast agents and other drugs (heparin, aspirin, clopidogrel, statin lipid-lowering drugs, etc.) (rashes are not counted) or unable to use iodine contrast agents and other drugs (heparin, aspirin, clopidogrel, statin lipid-lowering drugs, etc.) for various reasons; 7. The surgical instrument cannot reach the target blood vessel due to tortuous approach or other difficulties; 8. There is a history of major surgery within the recent 1 month, or the albumin is less than 18mg/L; 9. Active bleeding or known bleeding tendency, platelet count less than 50x10^9/L; 10. Combined with severe heart, liver, renal insufficiency or other serious advanced diseases; 11. Life expectancy is less than 1 year; 12. Other special circumstances are not suitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
modified Rankin score;

Countries

China

Contacts

Public ContactHe Guoyong

People's Hospital of Guangxi Zhuang Autonomous Region

460032739@qq.com+86 17307711383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026